A new study from the @rocklabtb.bsky.social in @natmicrobiol.nature.com finds that one of the most common drug resistance mutations in #tuberculosis creates subtle metabolic weaknesses that could be exploited with future combination therapies.
š: https://bit.ly/3RG6wj2
